CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $33,677,000 | -35.4% | 1,146,636 | +0.0% | 1.55% | -23.0% |
| Q2 2018 | $52,128,000 | -15.3% | 1,146,436 | -1.7% | 2.01% | -31.7% |
| Q1 2018 | $61,559,000 | -18.2% | 1,165,884 | -34.4% | 2.94% | -39.7% |
| Q4 2017 | $75,260,000 | +16.2% | 1,777,884 | +126.3% | 4.88% | -2.9% |
| Q3 2017 | $64,742,000 | +391.4% | 785,700 | +458.4% | 5.02% | +202.0% |
| Q2 2017 | $13,174,000 | -42.2% | 140,700 | -70.7% | 1.66% | -42.9% |
| Q1 2017 | $22,791,000 | – | 479,700 | – | 2.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |